Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 00:15 | 2026-03-02 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; CHIEF EXECUTIVE OFFICER | Surgical & Medical Instruments & Apparatus | BUY | $8.96 | 11,200 | $100,309 | 342,034 | +3.4% |
| 2025-11-13 19:53 | 2025-11-11 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; CHIEF EXECUTIVE OFFICER | Surgical & Medical Instruments & Apparatus | BUY | $8.53 | 11,500 | $98,049 | 330,834 | +3.6% |
| 2023-12-12 01:02 | 2023-12-08 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; Chief Executive Officer | Surgical & Medical Instruments & Apparatus | BUY | $2.94 | 34,000 | $99,960 | 262,345 | +14.9% |
| 2023-03-30 16:00 | 2023-03-29 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; Chief Executive Officer | Surgical & Medical Instruments & Apparatus | BUY | $4.84 | 19,646 | $95,087 | 197,235 | +11.1% |
| 2022-12-14 23:33 | 2022-12-13 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; Chief Executive Officer | Surgical & Medical Instruments & Apparatus | BUY | $2.90 | 51,725 | $150,003 | 177,589 | +41.1% |
| 2022-07-21 17:29 | 2022-07-20 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; Chief Executive Officer | Surgical & Medical Instruments & Apparatus | BUY | $3.98 | 62,814 | $250,000 | 125,864 | +99.6% |
| 2022-04-19 04:23 | 2022-04-18 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; See Remarks | Surgical & Medical Instruments & Apparatus | BUY | $6.37 | 2,000 | $12,734 | 63,050 | +3.3% |
| 2022-04-09 01:25 | 2022-04-08 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; See Remarks | Surgical & Medical Instruments & Apparatus | BUY | $6.57 | 2,000 | $13,136 | 61,050 | +3.4% |
| 2021-12-07 02:06 | 2021-12-02 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; See Remarks | Surgical & Medical Instruments & Apparatus | BUY | $8.61 | 23,200 | $199,752 | 59,050 | +64.7% |
| 2021-06-29 20:46 | 2021-06-25 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; Chief Executive Officer | Surgical & Medical Instruments & Apparatus | BUY | $11.63 | 12,850 | $149,472 | 35,850 | +55.9% |
| 2021-04-05 19:34 | 2021-04-05 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; Chief Executive Officer | Surgical & Medical Instruments & Apparatus | BUY | $12.88 | 15,500 | $199,640 | 23,000 | +206.7% |
| 2020-12-14 22:00 | 2020-12-11 | DCTH | DELCATH SYSTEMS, INC. | MICHEL GERARD J | Director, Officer; Chief Executive Officer | Surgical & Medical Instruments & Apparatus | BUY | $13.25 | 7,500 | $99,375 | 7,500 | +100.0% |
| 2019-08-16 23:06 | 2019-08-14 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $16.62 | 17,000 | $282,547 | 123,182 | -12.1% |
| 2019-07-17 23:17 | 2019-07-15 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $19.68 | 17,000 | $334,579 | 123,182 | -12.1% |
| 2019-06-12 23:07 | 2019-06-10 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $15.62 | 17,500 | $273,373 | 122,672 | -12.5% |
| 2019-05-14 23:23 | 2019-05-13 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $17.02 | 17,500 | $297,859 | 122,672 | -12.5% |
| 2019-04-10 23:12 | 2019-04-08 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $17.64 | 15,625 | $275,592 | 122,672 | -11.3% |
| 2019-03-12 23:12 | 2019-03-11 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | SALE | $20.02 | 10,000 | $200,235 | 122,249 | -7.6% |
| 2019-02-14 00:16 | 2019-02-11 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | SALE | $17.09 | 10,000 | $170,880 | 132,249 | -7.0% |
| 2019-01-17 00:00 | 2019-01-14 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | SALE | $17.18 | 8,711 | $149,627 | 142,249 | -5.8% |
| 2018-12-13 00:06 | 2018-12-10 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $16.81 | 15,625 | $262,656 | 150,960 | -9.4% |
| 2018-11-15 00:03 | 2018-11-12 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $15.90 | 15,000 | $238,500 | 150,960 | -9.0% |
| 2018-10-17 23:05 | 2018-10-15 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $12.65 | 15,000 | $189,750 | 150,960 | -9.0% |
| 2018-09-12 20:57 | 2018-09-10 | VCEL | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | OPT+S | $12.35 | 15,000 | $185,250 | 150,960 | -9.0% |
| 2014-09-18 00:17 | 2014-09-16 | ASTM | Vericel Corp | MICHEL GERARD J | Officer; CFO and VP, Corp. Development | Biological Products, (No Diagnostic Substances) | BUY | $2.55 | 20,000 | $51,000 | 20,000 | +100.0% |
| 2011-02-11 01:22 | 2011-02-08 | BIOD | N/A | MICHEL GERARD J | Officer; CFO, VP of Corp and Dev/Treas | Other | OPT+S | $2.05 | 4,000 | $8,200 | 31,125 | -11.4% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.